Phyllis Walsh is associate director of Merck and Company, Inc.
Third-Party Audits: Ensuring That Excipients Meet cGMP Requirements
Increasingly stringent audit requirements will make third-party accredited GMP audits critical for pharmaceutical excipients and raw materials.